Cross John Harry III (CIK 0001806763)

Latest company ownership

Shares held
1,588
Last filed at
Dec 5, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 6, 2023 Feb 17, 2023 Sonnet BioTherapeutics Holdings, Inc. CFO Sell 27.5 -1,960 -7.57% ✗ $2.1K